2024
Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco
Daaboul D, Osman M, Kassem I, Yassine I, Girlich D, Proust A, Mounir C, Zerouali K, Raymond J, Naas T, Oueslati S. Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco. Journal Of Antimicrobial Chemotherapy 2024, 79: 1614-1618. PMID: 38804143, DOI: 10.1093/jac/dkae153.Peer-Reviewed Original ResearchNeonatal intensive care unitBlaVIM-2BlaNDM-1Intensive care unitCenter of Genomic EpidemiologyBlaVIM-2 geneIntegrative conjugative elementsWhole-genome sequencingAntimicrobial resistance genesBlaNDM-1 geneAntimicrobial susceptibility testingCarbapenem-resistant Pseudomonas aeruginosaCare unitLast-resort antibioticsSusceptible to colistinResistance to cefiderocolXDR P. aeruginosaGram-negative bacteriaCarba NPMetallo-b-lactamasesReducing treatment optionsConjugative elementsSequence typingESBL genesMinION technologyExtensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears
Grossman M, Rankin D, Maloney M, Stanton R, Gable P, Stevens V, Ewing T, Saunders K, Kogut S, Nazarian E, Bhaurla S, Mephors J, Mongillo J, Stonehocker S, Prignano J, Valencia N, Charles A, McNamara K, Fritsch W, Ruelle S, Plucinski C, Sosa L, Ostrowsky B, Ham D, Walters M, Aguilar H, Alavi A, Balbuena R, Braut-Taormina J, Bruce H, Chambers W, Chen K, Clancy K, Cockrell M, Crayton K, Cyrus M, D'Angeli M, Diaz M, Dollete J, Eskenazi S, Fong L, Giardina R, Gogley J, Greendyke W, Hadman S, Houston H, Huck C, Istafanos P, Jean-Louis A, Jones D, Kratz M, Kwan T, La S, Lance S, Lasure M, Longo C, Machado M, McAllister G, McGarry S, McKay S, Miller D, Musk M, O'Yong K, Patel E, Pightling A, Rodriguez A, Rogers J, Romero H, Satyam M, Silverman M, Skolek G, Smith A, Stahl A, Torres L, Trivedi K, Wilmott N. Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears. Clinical Infectious Diseases 2024, 79: 6-14. PMID: 38315890, PMCID: PMC11259536, DOI: 10.1093/cid/ciae052.Peer-Reviewed Original ResearchCase-patientsCase-control studyDays of culture collectionCarbapenem-resistant Pseudomonas aeruginosaOver-the-counterArtificial tear useCarbapenemase-producing organismsDrug-resistant bacteriaCarbapenemase-producingSurveillance culturesPatient isolatesPreservative-freeClinical impactEye infectionsSpecimen sourceClinical culturesSequence typingIncreased oddsUnopened bottlesResistant bacteriaPost-acute care facilitiesCase statusBrand ABacterial contaminationCulture Collection
2018
Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients
Pettigrew MM, Gent JF, Kong Y, Halpin AL, Pineles L, Harris AD, Johnson JK. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients. Clinical Infectious Diseases 2018, 69: 604-613. PMID: 30383203, PMCID: PMC6669284, DOI: 10.1093/cid/ciy936.Peer-Reviewed Original ResearchConceptsCarbapenem-resistant Pseudomonas aeruginosaIntensive care unit patientsCare unit patientsPiperacillin-tazobactamUnit patientsICU patientsMarker of riskMaryland Medical CenterRisk of colonizationRibosomal RNA gene sequencingRNA gene sequencingAdmission swabCRPA infectionPseudomonas aeruginosaICU admissionPatient characteristicsMicrobiota disruptionMedical CenterGastrointestinal tractAdditional swabsAntimicrobial exposureLower riskEvaluated associationsPatientsProtective role
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply